☰

Ebenezer V. Tumban, Ph.D. - Publications

Affiliations: 
2007 New Mexico State University, Las Cruces, NM, United States 
Area:
Molecular Biology, Virology Biology
Tree Info Grants Similar researchers PubMed Report error

26/29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Tumban E. Bacteriophage Virus-Like Particles: Platforms for Vaccine Design. Methods in Molecular Biology (Clifton, N.J.). 2738: 411-423. PMID 37966612 DOI: 10.1007/978-1-0716-3549-0_24  0.356
2023 Kheirvari M, Liu H, Tumban E. Virus-like Particle Vaccines and Platforms for Vaccine Development. Viruses. 15. PMID 37243195 DOI: 10.3390/v15051109  0.388
2021 Zhai L, Anderson D, Bruckner E, Tumban E. Novel expression of coat proteins from thermophilic bacteriophage ΦIN93 and evaluation for assembly into virus-like particles. Protein Expression and Purification. 105932. PMID 34214599 DOI: 10.1016/j.pep.2021.105932  0.361
2021 Yadav R, Zhai L, Kunda NK, Muttil P, Tumban E. Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51. Viruses. 13. PMID 34200586 DOI: 10.3390/v13061113  0.386
2020 Basu R, Zhai L, Rosso B, Tumban E. Bacteriophage Qβ virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus. Vaccine. PMID 32044164 DOI: 10.1016/J.Vaccine.2020.01.091  0.447
2019 Yadav R, Zhai L, Tumban E. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today? Viruses. 12. PMID 31877975 DOI: 10.3390/V12010018  0.509
2019 Tumban E. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers. Viruses. 11: 922. PMID 31600915 DOI: 10.3390/V11100922  0.431
2019 Zhai L, Yadav R, Kunda NK, Anderson D, Bruckner E, Miller EK, Basu R, Muttil P, Tumban E. Oral immunization with bacteriophage MS2-L2 VLPs protects against oral and genital infection with multiple HPV types associated with head & neck cancers and cervical cancer. Antiviral Research. PMID 30926288 DOI: 10.1016/J.Antiviral.2019.03.012  0.473
2019 Kunda NK, Peabody J, Zhai L, Price DN, Chackerian B, Tumban E, Muttil P. Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9. Human Vaccines & Immunotherapeutics. PMID 30883270 DOI: 10.1080/21645515.2019.1593727  0.441
2018 Basu R, Zhai L, Contreras A, Tumban E. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells. Vaccine. PMID 29395533 DOI: 10.1016/J.Vaccine.2018.01.056  0.462
2017 Zhai L, Peabody J, Pang YS, Schiller J, Chackerian B, Tumban E. A novel candidate MS2 phage VLP vaccine displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9. Antiviral Research. PMID 28939477 DOI: 10.1016/J.Antiviral.2017.09.012  0.483
2017 Peabody J, Muttil P, Chackerian B, Tumban E. Characterization of a spray-dried candidate HPV L2-VLP vaccine stored for multiple years at room temperature. Papillomavirus Research (Amsterdam, Netherlands). 3: 116-120. PMID 28720444 DOI: 10.1016/J.Pvr.2017.03.004  0.495
2016 Basu R, Tumban E. Zika Virus on a Spreading Spree: what we now know that was unknown in the 1950's. Virology Journal. 13: 165. PMID 27716242 DOI: 10.1186/S12985-016-0623-2  0.423
2016 Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Research. 130: 101-9. PMID 27040313 DOI: 10.1016/J.Antiviral.2016.03.016  0.442
2016 Saboo S, Tumban E, Peabody J, Wafula D, Peabody DS, Chackerian B, Muttil P. Optimized Formulation of a Thermostable Spray-Dried Virus-Like Particle Vaccine against Human Papillomavirus. Molecular Pharmaceutics. 13: 1646-55. PMID 27019231 DOI: 10.1021/Acs.Molpharmaceut.6B00072  0.519
2015 Tumban E, Muttil P, Escobar CA, Peabody J, Wafula D, Peabody DS, Chackerian B. Preclinical refinements of a broadly protective VLP-based HPV vaccine targeting the minor capsid protein, L2. Vaccine. 33: 3346-53. PMID 26003490 DOI: 10.1016/J.Vaccine.2015.05.016  0.492
2014 Tyler M, Tumban E, Dziduszko A, Ozbun MA, Peabody DS, Chackerian B. Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing. Vaccine. 32: 4267-74. PMID 24962748 DOI: 10.1016/J.Vaccine.2014.06.054  0.513
2014 Tyler M, Tumban E, Peabody DS, Chackerian B. The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine. Biotechnology and Bioengineering. 111: 2398-406. PMID 24917327 DOI: 10.1002/Bit.25311  0.528
2014 Tyler M, Tumban E, Chackerian B. Second-generation prophylactic HPV vaccines: successes and challenges. Expert Review of Vaccines. 13: 247-55. PMID 24350614 DOI: 10.1586/14760584.2014.865523  0.475
2013 Tumban E, Peabody J, Peabody DS, Chackerian B. A universal virus-like particle-based vaccine for human papillomavirus: longevity of protection and role of endogenous and exogenous adjuvants. Vaccine. 31: 4647-54. PMID 23933337 DOI: 10.1016/J.Vaccine.2013.07.052  0.499
2013 Tumban E, Maes NE, Schirtzinger EE, Young KI, Hanson CT, Whitehead SS, Hanley KA. Replacement of conserved or variable sequences of the mosquito-borne dengue virus 3' UTR with homologous sequences from Modoc virus does not change infectivity for mosquitoes. The Journal of General Virology. 94: 783-8. PMID 23255623 DOI: 10.1099/Vir.0.046664-0  0.581
2012 Tumban E, Peabody J, Tyler M, Peabody DS, Chackerian B. VLPs displaying a single L2 epitope induce broadly cross-neutralizing antibodies against human papillomavirus. Plos One. 7: e49751. PMID 23185426 DOI: 10.1371/Journal.Pone.0049751  0.543
2011 Tumban E, Peabody J, Peabody DS, Chackerian B. A pan-HPV vaccine based on bacteriophage PP7 VLPs displaying broadly cross-neutralizing epitopes from the HPV minor capsid protein, L2. Plos One. 6: e23310. PMID 21858066 DOI: 10.1371/Journal.Pone.0023310  0.517
2011 Hunter Z, Tumban E, Dziduszko A, Chackerian B. Aerosol delivery of virus-like particles to the genital tract induces local and systemic antibody responses. Vaccine. 29: 4584-92. PMID 21549786 DOI: 10.1016/J.Vaccine.2011.04.051  0.541
2011 Tumban E, Mitzel DN, Maes NE, Hanson CT, Whitehead SS, Hanley KA. Replacement of the 3' untranslated variable region of mosquito-borne dengue virus with that of tick-borne Langat virus does not alter vector specificity. The Journal of General Virology. 92: 841-8. PMID 21216984 DOI: 10.1099/Vir.0.026997-0  0.593
2006 Romero TA, Tumban E, Jun J, Lott WB, Hanley KA. Secondary structure of dengue virus type 4 3' untranslated region: impact of deletion and substitution mutations. The Journal of General Virology. 87: 3291-6. PMID 17030863 DOI: 10.1099/Vir.0.82182-0  0.546
Low-probability matches (unlikely to be authored by this person)
2020 Tumban E. Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval. Viruses. 13. PMID 33396343 DOI: 10.3390/v13010054  0.29
2009 Tumban E, Painter JM, Lott WB. Comparison between the HCV IRES domain IV RNA structure and the Iron Responsive Element. Journal of Negative Results in Biomedicine. 8: 4. PMID 19226474 DOI: 10.1186/1477-5751-8-4  0.246
2023 Liu H, Kheirvari M, Tumban E. Potential Applications of Thermophilic Bacteriophages in One Health. International Journal of Molecular Sciences. 24. PMID 37175929 DOI: 10.3390/ijms24098222  0.132
Hide low-probability matches.